Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/BF02121649 http://scihub22266oqcxt.onion/10.1007/BF02121649 7382912!?!7382912 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=7382912&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Med+Microbiol+Immunol 1980 ; 168 (1): 25-34 Nephropedia Template TP {{tp|p=7382912|t=1980. Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents |pdf=|usr=}}{{7382912}} gab.com Text Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents JO: Med Microbiol Immunol http://www.kidney.de/pget.php?&tw=1&pmid=7382912 #FOAvip Intercalating agents, some of them in clinical use, were tested for their ability to inhibit the hepatitis B virus specific DNA polymerase reaction. Ethidium bromide was shown to be the strongest inhibitor among the compounds tested. Compounds in clinical use inhibited the DNA polymerase test only at high concentrations. The inhibitory activity of all compounds tested was increased when the MgCl2 content in the reaction mixture was lowered. UV absorption studies presented no evidence that this effect was due to complex formation of magnesium and the individual compounds. The therapeutic significance of these findings is not certain and needs further work. Twit Text FOAVip Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents ????Med Microbiol Immunol http://www.kidney.de/pget.php?&tw=1&pmid=7382912 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=7382912 #FOAvip English Wikipedia <ref>{{Cite pmid|7382912}}</ref> Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents #MMPMID7382912 Hess G; Arnold W; Moller B; Gahl GM; Meyer zum Buschenfelde KH Med Microbiol Immunol 1980[Feb]; 168 (1): 25-34 PMID7382912show ga Intercalating agents, some of them in clinical use, were tested for their ability to inhibit the hepatitis B virus specific DNA polymerase reaction. Ethidium bromide was shown to be the strongest inhibitor among the compounds tested. Compounds in clinical use inhibited the DNA polymerase test only at high concentrations. The inhibitory activity of all compounds tested was increased when the MgCl2 content in the reaction mixture was lowered. UV absorption studies presented no evidence that this effect was due to complex formation of magnesium and the individual compounds. The therapeutic significance of these findings is not certain and needs further work. |*Nucleic Acid Synthesis Inhibitors[MESH] |Carrier State/immunology[MESH] |Chloroquine/pharmacology[MESH] |DNA-Directed DNA Polymerase/blood[MESH] |Ethidium/pharmacology[MESH] |Hepatitis B Antigens/isolation & purification[MESH] |Hepatitis B virus/*enzymology[MESH] |Hepatitis B/enzymology/immunology[MESH] |Humans[MESH] |Intercalating Agents/*pharmacology[MESH] |Magnesium/pharmacology[MESH] |Methylene Blue/pharmacology[MESH] |Primaquine/pharmacology[MESH] |Quinacrine/pharmacology[MESH]Inhibition of hepatitis B virus specific DNA polymerase by intercalati(epmc).pdf DeepDyve Pubget Overpricing